Preview Mode Links will not work in preview mode

ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

Oct 25, 2022

In this interview, Martin Halle MD and Steven E. Nissen MD, MACC discuss a recent piece in JACC: Exercise for Primary and Secondary Prevention of Cardiovascular Disease.


Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to...

Oct 18, 2022

Any person with a smartphone can screen him- or herself for treatment-relevant atrial fibrillation - the world's most important arrhythmia. This could have huge impact on the prevention of stroke.

In this interview, Axel Bauer MD and Thomas F. Deering MD, FACC, with Sun Moon Kim MD, FSCAI, FACC, discuss ESC...

Oct 11, 2022

This subgroup analysis from the MASTER-DAPT trial demonstrates that in high-bleeding risk patients with acute or recent myocardial infarction it is safe to stop DAPT 1 month after stenting and that this strategy provides a reduction in bleeding risk.

In this interview, Pieter C. Smits MD, PhD, FESC and Sidney C. Smith...

Oct 4, 2022

In the DANCAVAS Trial, researchers found a remarkable reduction in death of any cause, and this might be a game changer in prevention of cardiovascular diseases.

In this interview, Axel Cosmus Pyndt Diederichsen MD and Clyde W. Yancy MD, MSc, MACC, FAHA, MACP, FHFSA, FASPC (Hon.) discuss ESC Late-Breaker: DANCAVAS:...